<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The rising incidence of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in western countries requires a new strategy in the management of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Esophagectomy, which has high morbidity and mortality rates, has been recommended to treat patients with severe <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Strictly superficial laser coagulation with tissue ablation therefore is a desirable option for the management of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> because the tissue to be ablated is only about 2 mm thick </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="120" ids="26216">Potassium</z:chebi>-titanyl-phosphate (KTP) laser light with a wavelength of 532 nm is preferentially absorbed by <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> and therefore combines excellent coagulation with limited tissue penetration </plain></SENT>
<SENT sid="4" pm="."><plain>We report first clinical results with KTP laser superficial vaporization of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and early <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: Eight men and 2 women 43 to 84 years of age with short segments of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> or traditional <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and histologically proved low-grade (n = 4) and high-grade (n = 4) <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or early <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (n = 2) were selected for this pilot study </plain></SENT>
<SENT sid="6" pm="."><plain>For <z:hpo ids='HP_0000001'>all</z:hpo> patients thermal endoscopic destruction was conducted with a frequency-doubled <z:chebi fb="7" ids="33372">neodymium</z:chebi>:<z:chebi fb="2" ids="33331">yttrium</z:chebi>-<z:chebi fb="6" ids="28984">aluminum</z:chebi>-garnet (Nd:YAG) KTP laser system </plain></SENT>
<SENT sid="7" pm="."><plain>Laser therapy was performed by means of the free-beam method with coaxial insufflation of gas </plain></SENT>
<SENT sid="8" pm="."><plain>An average of 2.4 sessions per patient were required for ablation of the Barrett's mucosa </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: Two to three days after laser treatment the response of the ablated mucosa was assessed with endoscopy and biopsy </plain></SENT>
<SENT sid="10" pm="."><plain>Samples taken showed fibrinoid <z:mp ids='MP_0001651'>necrosis</z:mp> of the mucosal layer </plain></SENT>
<SENT sid="11" pm="."><plain>A complete response was obtained for <z:hpo ids='HP_0000001'>all</z:hpo> 10 patients </plain></SENT>
<SENT sid="12" pm="."><plain>Replacement by <z:mpath ids='MPATH_458'>normal</z:mpath> squamous cell epithelium was induced in combination with acid suppression therapy of up to 80 mg <z:chebi fb="14" ids="7772">omeprazole</z:chebi> daily </plain></SENT>
<SENT sid="13" pm="."><plain>No complications occurred </plain></SENT>
<SENT sid="14" pm="."><plain>In two patients biopsy showed specialized mucosa beneath the restored squamous cell epithelial layer </plain></SENT>
<SENT sid="15" pm="."><plain>Follow-up times were as long as 15 months (mean value 10.6 months) </plain></SENT>
<SENT sid="16" pm="."><plain>CONCLUSIONS: KTP laser destruction of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> induced mucosal regeneration with <z:mpath ids='MPATH_458'>normal</z:mpath> squamous cell epithelium in combination with acid suppression </plain></SENT>
<SENT sid="17" pm="."><plain>Limitation of the depth of thermal destruction in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> minimizes risk for <z:mpath ids='MPATH_81'>perforation</z:mpath> or stricture formation </plain></SENT>
<SENT sid="18" pm="."><plain>KTP laser ablation of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> seems to be feasible and safe in short segments of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> with <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or early <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>